Bayaspirin

Developed for: cerebrovascular disorder
Investigated by: Chinese PLA General Hospital · Peking University People's Hospital · Xuanwu Hospital, Beijing

today NCT03471169 · Ph 1

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03471169	Apr 2017 → Dec 2018	cerebrovascular disorder	Xuanwu Hospital, Beijing	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Bayaspirin	“Antithrombotic drugs inclued Bayaspirin®，Plavix ® and Cilostazol.” NCT03471169 ↗